Company intelligence / Profile preview

Momentum Biotechnologies

Billerica, MA, United Statesdirectory.ncbiotech.org ↗

Ownership: Private
Development stage: Commercial

Overview

Momentum Biotechnologies provides advanced mass spectrometry services—including ASMS, covalent binding assays, chemoproteomics—to accelerate lead discovery and target validation for biopharma clients worldwide. The acquisition of OmicScouts expanded their proteomic assay portfolio and European presence. No proprietary clinical results as they do not develop their own therapeutics.

Modalities: Small moleculeCovalent drugs and degradersPeptides (via DNA encoded libraries)
Industry: Drug Discovery Services

Partnerships

Collaborates with top pharmaceutical and biotechnology companies as clients; specific partnerships not disclosed publicly.

Beyond the preview

Go deeper on Momentum Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Momentum Biotechnologies.

Explore the full profile